MediPharm Labs (MEDIF) announces it has launched the new Shake & Puff CBN THC Nighttime Inhaler in Canada. This innovative product expands MediPharm’s leading CBN oil product portfolio and builds on the success of the Company’s THC Inhaler introduced earlier this year. The new metered dose inhaler delivers a precise formulation of minor cannabinoid CBN and THC in a consistent, smoke-free format.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDIF:
- MediPharm Labs Announces 2025 Shareholder Meeting Results and Board Changes
- Medipharm Labs announces voting results from Annual, Special Meeting
- MediPharm Labs Urges Patience Amid Premature Meeting Outcome Claims
- Medipharm announces Glass Lewis recommends shareholders vote for all nominees
- MediPharm Labs Advocates for Current Strategy Amid Shareholder Vote